we have the right to move forward with these assets if successful, in exchange of a fee we will acquire these assets.
this is my understanding.
no way can we support all assets.
what is important now is that we have a clear priority on our phase 1 study beginning in the coming weeks and our phase 2 asset is being assessed by the FDA regarding phase 3 start or phase 2b starting in Q4.
I might email Riccardo to see if the company intends to release a presentation with a timeline in the coming 4-6 weeks.
we have the right to move forward with these assets if...
Add RAD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
-0.004(9.52%) |
Mkt cap ! $17.62M | |||
| Open | High | Low | Value | Volume |
| 3.9¢ | 4.0¢ | 3.8¢ | $18.95K | 477.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 316315 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.0¢ | 55401 | 2 |
View Market Depth
| Last trade - 15.59pm 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
3.9¢ |
Change
-0.004 ( 4.88 %) |
||||
| Open | High | Low | Volume | ||
| 3.9¢ | 4.0¢ | 3.9¢ | 54547 | ||
| Last updated 15.47pm 08/05/2024 ? | |||||
| RAD (ASX) Chart |